Mechanism for Mutational Inactivation of the Tumor Suppressor Smad2

REFERENCES

• Abdollah, S., M. Macias-Silva, T. Tsukazaki, H. Hayashi, L. Attisano, and J. L. Wrana. 1997. TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272:27678–27685.
   PubMed Web of Science ®Google Scholar
• Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499
   PubMed Web of Science ®Google Scholar
• Atfi, A., K. Lepage, P. Allard, A. Chapdelaine, and S. Chevalier. 1995. Activation of a serine/threonine kinase signaling pathway by TGF-β. Proc. Natl. Acad. Sci. USA 92:12110–12114.
   PubMed Web of Science ®Google Scholar
• Atfi, A., M. Buisine, A. Mazars, and C. Gespach. 1997. Induction of apoptosis by DPC4, a transcriptional factor regulated by TGF-β through SAPK/JNK signaling pathway. J. Biol. Chem. 272:24731–24734.
   PubMed Web of Science ®Google Scholar
• Atfi, A., S. Djelloul, E. Chastre, R. Davis, and C. Gespach. 1997. Evidence for a role of Rho-like GTPases SAPK/JNK in TGF-β-mediated signaling. J. Biol. Chem. 272:1429–1432.
   PubMed Web of Science ®Google Scholar
• Baker, J. C., and R. M. Harland. 1996. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10:1880–1889.
   PubMedGoogle Scholar
• Chen, X., M. J. Rubock, and M. A. Whitman. 1996. Transcriptional partner for MAD proteins in TGF-β signaling. Nature 383:691–696.
   PubMedGoogle Scholar
• Chen, X., E. Weisberg, V. Fridmacher, M. Watanabe, G. Naco, and M. Whitman. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389:85–89.
   PubMed Web of Science ®Google Scholar
• Dai, J. L., R. K. Bansal, and S. E. Kern. 1999. G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation. Proc. Natl. Acad. Sci. USA 96:1427–1432.
   PubMedGoogle Scholar
• Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J. M. Gauthier. 1998. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091–3100.
   PubMed Web of Science ®Google Scholar
• Derynck, R., and X. H. Feng. 1997. TGF-β receptor signaling. Biochim. Biophys. Acta 1333:105–150.
   PubMed Web of Science ®Google Scholar
• Derynck, R., Y. Zhang, and X. H. Feng. 1998. Smads: transcriptional activators of TGF-β responses. Cell 95:737–740.
   PubMed Web of Science ®Google Scholar
• Eppert, K., S. W. Scherer, H. Ozcelik, R. Pirone, P. Hoodless, H. Kim, L. C. Tsui, B. Bapat, S. Gallinger, I. L. Andrulis, G. H. Thomsen, J. L. Wrana, and L. Attisano. 1996. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543–552.
   PubMed Web of Science ®Google Scholar
• Hahn, S. A., M. Schutte, A. T. Hoque, C. A. Moskaluk, L. T. daCosta, E. Rozenblum, C. L. Weinstein, A. Fischer, C. J. Yeo, R. H. Hruban, and S. E. Kern. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353.
   PubMed Web of Science ®Google Scholar
• Hayashi, H., S. Abdollah, Y. Qiu, J. Cai, Y. Y. Xu, B. W. Grinnell, M. A. Richardson, J. N. Topper, M. A. Gimbrone Jr., J. L. Wrana, and D. Falb. 1997. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89:1165–1173.
   PubMed Web of Science ®Google Scholar
• Heldin, C. H., K. Miyazono, and P. ten Dijke. 1997. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471.
   PubMed Web of Science ®Google Scholar
• Hunter, T.. 1997. Oncoprotein networks. Cell 88:333–346.
   PubMed Web of Science ®Google Scholar
• Imamura, T., M. Takase, A. Nishihara, E. Oeda, J. Hanai, M. Kawabata, and K. Miyazono. 1997. Smad6 inhibits signaling by the TGF-β superfamily. Nature 389:622–626.
   PubMed Web of Science ®Google Scholar
• Kawabata, M., H. Inoue, A. Hanyu, T. Imamura, and K. Miyazono. 1998. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17:4056–4065.
   PubMedGoogle Scholar
• Kretzschmar, M., J. Doody, I. Timokhina, and J. Massagué. 1999. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev. 13:804–816.
   PubMed Web of Science ®Google Scholar
• Lagna, G., A. Hata, A. Hemmati-Brivanlou, and J. Massagué. 1996. Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways. Nature 383:832–836.
   PubMed Web of Science ®Google Scholar
• Lo, R. S., U.-G. Chen, Y. Shi, N. P. Pavletich, and J. Massagué. 1998. The L3 loop: a structural motif determining specific interactions between Smad proteins and TGF-β receptors. EMBO J. 17:996–1005.
   PubMed Web of Science ®Google Scholar
• Lu, S. L., W. C. Zhang, Y. Akiyama, T. Nomizu, and Y. Yuasa. 1996. Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res. 56:4595–4598.
   PubMedGoogle Scholar
• Macias-Silva, M., S. Abdollah, P. A. Hoodless, R. Pirone, L. Attisano, and J. L. Wrana. 1996. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:215–224.
   Google Scholar
• Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, M. Brattain, and J. K. V. Willson. 1995. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338.
   PubMed Web of Science ®Google Scholar
• Massagué, J.. 1998. TGF-β signal transduction. Annu. Rev. Biochem. 67:753–791.
   PubMed Web of Science ®Google Scholar
• Massagué, J., and Y.-G. Chen. 2000. Controlling TGF-β signaling. Genes Dev. 14:627–644.
   PubMed Web of Science ®Google Scholar
• Nakao, A., T. Imamura, S. Souchelnytskyi, M. Kawabata, A. Ishisaki, E. Oeda, K. Tamaki, J. Hanai, C. H. Heldin, K. Miyazono, and P. ten Dijke. 1997. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J. 16:5353–5362.
   PubMed Web of Science ®Google Scholar
• Nakao, A., M. Afrakhte, A. Moren, T. Nakayama, J. L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N. E. Heldin, C. H. Heldin, and P. ten Dijke. 1997. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signaling. Nature 389:631–635.
   PubMed Web of Science ®Google Scholar
• Nomura, M., and E. Li. 1998. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393:786–790.
   PubMedGoogle Scholar
• Prunier, C., A. Mazars, V. Noe, E. Bruyneel, M. Mareel, C. Gespach, and A. Atfi. 1999. Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion. J. Biol. Chem. 274:22919–22922.
   PubMedGoogle Scholar
• Riggins, G. J., K. W. Kinzler, B. Vogelstein, and S. Thiagalingam. 1997. Frequency of Smad gene mutations in human cancers. Cancer Res. 57:2578–2580.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., and M. B. Sporn. 1990. The transforming growth factors-βs. Peptide growth factors and their receptors.. A. B. Roberts, and M. B. Sporn. 421–472. Springer-Verlag, Heidelberg, Germany
   Google Scholar
• Shi, Y., A. Hata, R. S. Lo, J. Massagué, and N. P. Pavletich. 1997. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388:87–93.
   PubMed Web of Science ®Google Scholar
• Souchelnytskyi, S., K. Tamaki, U. Engstrom, C. Wernstedt, P. ten Dijke, and C. H. Heldin. 1997. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J. Biol. Chem. 272:28107–28115.
   PubMed Web of Science ®Google Scholar
• Takaku, K., M. Oshima, H. Miyoshi, M. Matsui, M. F. Seldin, and M. M. Taketo. 1998. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92:645–656.
   PubMed Web of Science ®Google Scholar
• Uchida, K., M. Nagatake, H. Osada, Y. Yatabe, M. Kondo, T. Mitsudomi, A. Masuda, T. Takahashi, and T. Takahashi. 1996. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 56:5583–5585.
   PubMedGoogle Scholar
• Waldrip, W. R., E. K. Bikoff, P. A. Hoodless, J. L. Wrana, and E. J. Robertson. 1998. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92:797–808.
   PubMed Web of Science ®Google Scholar
• Whitman, M.. 1998. Smads and early developmental signaling by the TGF-β superfamily. Genes Dev. 12:2445–2462.
   PubMed Web of Science ®Google Scholar
• Wieser, R., J. L. Wrana, and J. Massagué. 1995. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14:2199–2208.
   PubMedGoogle Scholar
• Wrana, J. L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X. F. Wang, and J. Massagué. 1992. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 11:1003–1014.
   Google Scholar
• Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. 1994. Mechanism of activation of the TGF-β receptor. Nature 370:341–347.
   PubMed Web of Science ®Google Scholar
• Wu, G., Y. G. Chen, B. Ozdamar, C. A. Gyuricza, P. A. Chong, J. L. Wrana, J. Massagué, and Y. Shi. 2000. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science 287:92–97.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., X. Feng, R. We, and R. Derynck. 1996. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168–172.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., T. Musci, and R. Derynck. 1997. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr. Biol. 7:270–276.
   PubMed Web of Science ®Google Scholar